A UCLA-led study suggests women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function.
FDA+ roundup: FDA continues to loosen standard of evidence for novel drug approvals — JAMA research letter
The FDA is continuing to lower the bar of its approval standards for novel drug applications, according to a new analysis of evidence on approvals
August 10, 2023